6 questions for the medtech industry if Congress doesn’t reauthorize FDA user fees on time
If Congress doesn’t pass the legislation before Sept. 30, furloughs and delays lie ahead for the agency.
If Congress doesn’t pass the legislation before Sept. 30, furloughs and delays lie ahead for the agency.
“We can’t be in … primary care without M&A. We’ve been very clear about that,” CEO Karen Lynch said during an earnings call Wednesday.
The payer raised its revenue and operation income targets for the year as a result of the quarterly performance.
The order follows the DOJ’s decision to sue Idaho over its near-total abortion ban as the end of Roe has left states to decide whether to ban the procedure.
The move reflects “significant increases in labor costs and weakness in volumes and acuity mix driving a downturn in the company’s revenue and margin levels,” according to a release.
Policy experts are worried, however, that progress on health coverage expansion will be threatened when a moratorium on Medicaid disenrollment ends.
The company raised its full-year guidance despite a $77 million decrease in adjusted operating income, primarily due to declines in its retail segment.
The president tapped two leaders with emergency management and public health backgrounds to lead the nation’s response to the disease as cases continue to climb.
Planned strikers include psychologists, therapists, chemical dependency counselors and social workers who say they’re stretched too thin and unable to provide adequate care to patients with mental health conditions.
COVID-19 patient volumes fell rapidly from the first to second quarter across chains’ hospitals as case counts waned, executives said on calls with investors.